ClinicalTrials.gg
Drug

Bezisterim clinical trials

Also written NE3107, HE3286 and Triolex.

studies test it
11
open now
0
in phase 3
1
first study started
2007

How each study uses bezisterim is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

bezisterim
2

Brand

Triolex
3

Development codes

NE3107
6
HE3286
5

Studies by the year they started

11 studies that test it; most in 2008 (3)

Studies that test bezisterim, by start year
YearStudies
20071
20083
20091
20211
20222
20231
20252

By phase

A phase 1/2 study counts in both.

Phase 1
5
Phase 2
8
Phase 3
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 9 · Other 2

Harbor Therapeutics (5) · BioVie Inc. (4) · Neurological Associates of West Los Angeles (2)

Studies

Open first, then newest update. How each study uses bezisterim is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 11

Codes

What other systems call bezisterim · ClinicalTrials.gg INT005192

  • UNII (FDA) PH8858757IBEZISTERIMConfirmed FDA, Wikidata
  • Wikidata Q27286562bezisterimConfirmed FDA, Wikidata
  • NCI Thesaurus C203210BezisterimOne source FDA
  • DrugBank DB05212One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.